Change in testing for blood glucose during the COVID-19 pandemic, United States 2019-2021.

ABSTRACT:

Aim

This study assessed changes in testing for blood glucose in the United States (US) from 2019 to 2021.

Methods

We conducted a serial cross-sectional analysis of the 2019-2021 National Health Interview Survey by including adults aged ≥ 18 years without reported diagnosed diabetes. We estimated the prevalence of testing for blood glucose within 12 months and the difference in the testing prevalence between 2019 and 2021.

Results

The study sample included 82,594 respondents without diabetes in 2019--2021, with a mean age between 46.4 and 46.8 years. Overall, the prevalence of testing for blood glucose decreased significantly from 64.2 % (95 % confidence interval [CI] 63.3 %, 65.1 %) in 2019 to 60.0 % (95 % CI 59.1 %, 60.9 %) in 2021. Among adults who met the United St

SUBMITTER: Miyamoto Y 

PROVIDER: S-EPMC11226753 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature